13F HOLDINGS REPORT
Artal Group S.A.
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001053906-24-000012
Total Value
$2.38B
Positions
2
Other Managers
4
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 17,507,990 | $2.17B | 91.02% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $213.8M | 8.98% |